Literature DB >> 22394662

Medicine use of elderly Chinese and Vietnamese immigrants and attitudes to home medicines review.

Lesley White1, Christiane Klinner.   

Abstract

There is a paucity of research into the perceptions of elderly Australian ethnic minorities towards public health services related to quality use of medicines. Among the six fastest growing ethnic groups in Australia, the Mandarin-speaking Chinese and Vietnamese constitute the largest elderly populations with poor English skills. This paper investigates the relationships of elderly Chinese and Vietnamese migrants with medicines, general practitioners and pharmacists, and how these relationships influence their awareness and attitudes of the home medicines review (HMR) program. Two semi-structured focus groups were held with a total of 17 HMR-eligible patients who have never received a HMR, one with Chinese and one with Vietnamese respondents, each in the respective community language. Confusion about medications and an intention to have a HMR were pronounced among all participants although none of them had heard of the program before participating in the focus groups. Respondents reported difficulties locating a pharmacist who spoke their native language, which contributed to an increased unmet need for medicine information. The Chinese group additionally complained about a lack of support from their general practitioners in relation to their medicine concerns and was adamant that they would prefer to have a HMR without the involvement of their general practitioner. Our results indicate a distinct HMR need but not use among elderly Chinese and Vietnamese eligible patients with poor English skills. Home medicines review service use and perceived medication problems are likely to improve with an increasing availability of bilingual and culturally sensitive health care providers.

Entities:  

Mesh:

Year:  2012        PMID: 22394662     DOI: 10.1071/PY10099

Source DB:  PubMed          Journal:  Aust J Prim Health        ISSN: 1448-7527            Impact factor:   1.307


  7 in total

1.  Polypharmacy in Patients with Ovarian Cancer.

Authors:  Sean Oldak; Stephanie Ioannou; Priyanka Kamath; Marilyn Huang; Sophia George; Brian Slomovitz; Matthew Schlumbrecht
Journal:  Oncologist       Date:  2019-04-05

2.  Patterns of pharmaceutical use for immigrants to Spain and Norway: a comparative study of prescription databases in two European countries.

Authors:  Luis Andres Gimeno-Feliu; Amaia Calderón-Larrañaga; Alexandra Prados-Torres; Concha Revilla-López; Esperanza Diaz
Journal:  Int J Equity Health       Date:  2016-02-24

Review 3.  Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.

Authors:  Lutfun N Hossain; Fernando Fernandez-Llimos; Tim Luckett; Joanna C Moullin; Desire Durks; Lucia Franco-Trigo; Shalom I Benrimoj; Daniel Sabater-Hernández
Journal:  BMJ Open       Date:  2017-09-05       Impact factor: 2.692

4.  The safety of health care for ethnic minority patients: a systematic review.

Authors:  Ashfaq Chauhan; Merrilyn Walton; Elizabeth Manias; Ramesh Lahiru Walpola; Holly Seale; Monika Latanik; Desiree Leone; Stephen Mears; Reema Harrison
Journal:  Int J Equity Health       Date:  2020-07-08

Review 5.  Current perspectives on pharmacist home visits: do we keep reinventing the wheel?

Authors:  Priti S Flanagan; Andrea Barns
Journal:  Integr Pharm Res Pract       Date:  2018-10-01

6.  Overuse or underuse? Use of healthcare services among irregular migrants in a north-eastern Spanish region.

Authors:  Luis Andrés Gimeno-Feliu; Marta Pastor-Sanz; Beatriz Poblador-Plou; Amaia Calderón-Larrañaga; Esperanza Díaz; Alexandra Prados-Torres
Journal:  Int J Equity Health       Date:  2021-01-20

7.  Diabetes care and service access among elderly Vietnamese with type 2 diabetes.

Authors:  Mary C Carolan-Olah; Angie Cassar; Regina Quiazon; Sean Lynch
Journal:  BMC Health Serv Res       Date:  2013-10-29       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.